Home > Insider Trading > Filing (0001209191-23-023402)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1863127	Tyra Biosciences Inc.	TYRA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711463	Todd Harris	C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-03	2,000	$2.25	1,703,276	No	4	M	Direct
Common Stock	Disposition	2023-04-03	2,000	$16.13	1,701,276	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-04-03	2,000	$0.00	2,000	$2.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
397,537		2031-03-09	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 and $16.240. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.